Sheng et al. treated ulcerative colitis mice with Bifidobacterium spp. and found that Bifidobacterium spp. could reduce the disease activity index, down-regulate the levels of IL-1β, and inhibit the mRNA expression of NLRP3 [24]. The gene discussed is IL1B; the disease is ulcerative colitis.